315 related articles for article (PubMed ID: 31368893)
21. Meta-Analysis Comparing Drug-Coated Balloons and Percutaneous Transluminal Angioplasty for Infrapopliteal Artery Disease.
Barbarawi M; Qazi AH; Lee J; Barbarawi O; Al-Abdouh A; Mhanna M; Vashist A
Am J Cardiol; 2022 Nov; 183():115-121. PubMed ID: 36116953
[TBL] [Abstract][Full Text] [Related]
22. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
[TBL] [Abstract][Full Text] [Related]
23. 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon.
Sachar R; Soga Y; Ansari MM; Kozuki A; Lopez L; Brodmann M; Schroë H; Ramanath VS; Diaz-Cartelle J; Zeller T;
JACC Cardiovasc Interv; 2021 May; 14(10):1123-1133. PubMed ID: 34016410
[TBL] [Abstract][Full Text] [Related]
24. Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries.
Geraghty PJ; Adams G; Schmidt A;
J Vasc Surg; 2021 Mar; 73(3):918-929.e5. PubMed ID: 32956797
[TBL] [Abstract][Full Text] [Related]
25. Excimer laser atherectomy combined with drug-coated balloon versus drug-eluting balloon angioplasty for the treatment of infrapopliteal arterial revascularization in ischemic diabetic foot: 24-month outcomes.
Yang S; Li S; Hou L; He J
Lasers Med Sci; 2022 Apr; 37(3):1531-1537. PubMed ID: 34647190
[TBL] [Abstract][Full Text] [Related]
26. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
Schneider PA; Laird JR; Doros G; Gao Q; Ansel G; Brodmann M; Micari A; Shishehbor MH; Tepe G; Zeller T
J Am Coll Cardiol; 2019 May; 73(20):2550-2563. PubMed ID: 30690141
[TBL] [Abstract][Full Text] [Related]
27. Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.
Shishehbor MH; Schneider PA; Zeller T; Razavi MK; Laird JR; Wang H; Tieché C; Parikh SA; Iida O; Jaff MR
J Vasc Surg; 2019 Oct; 70(4):1177-1191.e9. PubMed ID: 31543165
[TBL] [Abstract][Full Text] [Related]
28. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV
J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383
[TBL] [Abstract][Full Text] [Related]
29. Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
Shishehbor MH; Zeller T; Werner M; Brodmann M; Parise H; Holden A; Lichtenberg M; Parikh SA; Kashyap VS; Pietras C; Tirziu D; Ardakani S; Beschorner U; Krishnan P; Niazi KA; Wali AU; Lansky AJ
Circulation; 2022 May; 145(22):1645-1654. PubMed ID: 35377157
[TBL] [Abstract][Full Text] [Related]
30. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
[TBL] [Abstract][Full Text] [Related]
31. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
[TBL] [Abstract][Full Text] [Related]
32. Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial.
Liao CJ; Song SH; Li T; Zhang YZAW
Vascular; 2022 Jun; 30(3):448-454. PubMed ID: 34024196
[TBL] [Abstract][Full Text] [Related]
33. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; von Flotow P; Heilmeier B; Sixt S; Brucks S; Erbel C; Beschorner U; Werk M; Riambau V; Wienke A; Klumb CT; Thieme M
Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
[TBL] [Abstract][Full Text] [Related]
34. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; Sixt S; Brucks S; Beschorner U; Klumb CT; Thieme M;
EuroIntervention; 2020 Apr; 15(18):e1633-e1640. PubMed ID: 31687933
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of atherectomy combined with percutaneous transluminal angioplasty (PTA)/drug-coated balloon (DCB) compared with PTA/DCB for infrapopliteal arterial diseases: A systematic review and meta-analysis.
Wang H; Su Z; Guo J; Guo J; Gu Y
Vascular; 2024 May; ():17085381241252861. PubMed ID: 38715518
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
38. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results.
Brodmann M; Wissgott C; Brechtel K; Nikol S; Zeller T; Lichtenberg M; Blessing E; Gray W;
J Vasc Surg; 2020 Nov; 72(5):1636-1647.e1. PubMed ID: 32414527
[TBL] [Abstract][Full Text] [Related]
39. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
Bausback Y; Wittig T; Schmidt A; Zeller T; Bosiers M; Peeters P; Brucks S; Lottes AE; Scheinert D; Steiner S
J Am Coll Cardiol; 2019 Feb; 73(6):667-679. PubMed ID: 30765033
[TBL] [Abstract][Full Text] [Related]
40. A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease.
Forrestal BJ; Zhang C; Case BC; Yerasi C; Craig PE; Torguson R; Bernardo NL; Waksman R
Cardiovasc Revasc Med; 2021 Dec; 33():49-54. PubMed ID: 34090794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
